Toll Free: 1-888-928-9744

Actinium Pharmaceuticals, Inc. - Product Pipeline Review - 2016

Published: Aug, 2016 | Pages: 45 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Actinium Pharmaceuticals, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct's, 'Actinium Pharmaceuticals, Inc. - Product Pipeline Review - 2016', provides an overview of the Actinium Pharmaceuticals, Inc.'s pharmaceutical research and development focus. 

The report provides comprehensive information on the therapeutics under development by Actinium Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Actinium Pharmaceuticals, Inc.
- The report provides overview of Actinium Pharmaceuticals, Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report assesses Actinium Pharmaceuticals, Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report features Actinium Pharmaceuticals, Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons To Buy

- Evaluate Actinium Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Actinium Pharmaceuticals, Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Actinium Pharmaceuticals, Inc.'s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Actinium Pharmaceuticals, Inc. Snapshot 5 Actinium Pharmaceuticals, Inc. Overview 5 Key Information 5 Key Facts 5 Actinium Pharmaceuticals, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Actinium Pharmaceuticals, Inc. - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Actinium Pharmaceuticals, Inc. - Pipeline Products Glance 12 Actinium Pharmaceuticals, Inc. - Late Stage Pipeline Products 12 Phase III Products/Combination Treatment Modalities 12 Actinium Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Phase I Products/Combination Treatment Modalities 14 Actinium Pharmaceuticals, Inc. - Early Stage Pipeline Products 15 Preclinical Products/Combination Treatment Modalities 15 Actinium Pharmaceuticals, Inc. - Drug Profiles 16 Iomab-B 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Actimab-A 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 BC-8Y90 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 BC-8SA 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Actimab-B 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Actimab-Br 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Actimab-C 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Actimab-P 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 Monoclonal Antibody Conjugate for Hematological Tumor and Oncology 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 Monoclonal Antibody Conjugate for Oncology 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 Actinium Pharmaceuticals, Inc. - Pipeline Analysis 28 Actinium Pharmaceuticals, Inc. - Pipeline Products by Target 28 Actinium Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 29 Actinium Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 30 Actinium Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 31 Actinium Pharmaceuticals, Inc. - Recent Pipeline Updates 32 Actinium Pharmaceuticals, Inc. - Dormant Projects 41 Actinium Pharmaceuticals, Inc. - Discontinued Pipeline Products 42 Discontinued Pipeline Product Profiles 42 Bismab-A 42 Actinium Pharmaceuticals, Inc. - Locations And Subsidiaries 43 Head Office 43 Appendix 44 Methodology 44 Coverage 44 Secondary Research 44 Primary Research 44 Expert Panel Validation 44 Contact Us 44 Disclaimer 45
List of Tables
Actinium Pharmaceuticals, Inc., Key Information 5 Actinium Pharmaceuticals, Inc., Key Facts 5 Actinium Pharmaceuticals, Inc. - Pipeline by Indication, 2016 8 Actinium Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016 10 Actinium Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016 11 Actinium Pharmaceuticals, Inc. - Phase III, 2016 12 Actinium Pharmaceuticals, Inc. - Phase II, 2016 13 Actinium Pharmaceuticals, Inc. - Phase I, 2016 14 Actinium Pharmaceuticals, Inc. - Preclinical, 2016 15 Actinium Pharmaceuticals, Inc. - Pipeline by Target, 2016 28 Actinium Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016 29 Actinium Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016 30 Actinium Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2016 31 Actinium Pharmaceuticals, Inc. - Recent Pipeline Updates, 2016 32 Actinium Pharmaceuticals, Inc. - Dormant Developmental Projects,2016 41 Actinium Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2016 42



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify